- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07542431
Impact de l'Adoption et du Dressage de Chiens chez les Anciens Combattants Présentant des Symptômes de Stress Post-traumatique et/ou d'Autres Troubles de Santé Mentale (VCRM)
Évaluation des indicateurs biopsychosociaux liés à la réponse au traitement par intervention canine chez les anciens combattants présentant des symptômes de stress post-traumatique et/ou d'autres troubles de santé mentale
The goal of this single-arm study is to learn if a dog adoption and training program can treat, prevent in [describe participant population/primary condition; could include any of the following: sex/gender, age groups, healthy volunteers]. The main questions it aims to answer are:
- Does the dog adoption and training program decrease posttraumatic stress symptoms in veterans with self-reported posttraumatic stress symptoms?
- Does the dog adoption and training program decrease stress and improve psychosocial health in veterans with self-reported posttraumatic stress symptoms?
- Does the dog adoption and training program decrease inflammation, increase oxytocin, and change the structure and resting-state function of specific brain regions in veterans with self-reported posttraumatic stress symptoms?
Participants will:
- Attend eight one-hour professional dog training sessions within a 10-week period.
- Visit the clinical research unit four times during the study for data collection.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Beth A Pratt, PhD
- Numéro de téléphone: 561-297-4227
- E-mail: bpratt4@health.fau.edu
Lieux d'étude
-
-
Florida
-
Boca Raton, Florida, États-Unis, 33431
- Recrutement
- Florida Atlantic University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Military veteran with self-reported posttraumatic stress symptoms and/or other mental health conditions
- Over 18 years of age
- Applied and approved to adopt a shelter dog for training through the Humane Society of Broward County in Fort Lauderdale, Florida
- English speaker (written and spoken)
- Home internet access via tablet, computer or smartphone.
Exclusion Criteria:
- Fear of dogs
- Allergies to pet dander
- Uncorrected hearing or visual impairment.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Study Intervention
Within-subjects design |
Eight, one-hour professional dog training sessions over 8-10 weeks |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in self-reported posttraumatic stress disorder (PTSD) symptoms from baseline to 4 weeks post-intervention
Délai: From enrollment to 4 weeks post-intervention
|
Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) is a 20-item self-report measure of PTSD symptoms with scores ranging from 0 to 80. |
From enrollment to 4 weeks post-intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in depression symptom severity from baseline to 4 weeks post-intervention
Délai: From enrollment to 4 weeks post-intervention
|
Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report measure of depressive symptoms with scores ranging from 0 to 27. |
From enrollment to 4 weeks post-intervention
|
|
Change in anxiety symptom severity from baseline to 4 weeks post-intervention
Délai: From enrollment to 4 weeks post-intervention
|
Generalized Anxiety Disorder-7 (GAD-7) is a is a 7-item self-report measure of anxiety symptoms with scores ranging from 0 to 21. |
From enrollment to 4 weeks post-intervention
|
|
Change in perceived stress severity from baseline to 4 weeks post-intervention
Délai: From enrollment to 4 weeks post-intervention
|
Perceived Stress Scale-10 (PSS-10) is a 10-item self-report measure of perceived stress symptoms with scores ranging from 0 to 40. |
From enrollment to 4 weeks post-intervention
|
|
Change in sleep disturbance from baseline to 4 weeks post-intervention
Délai: From enrollment to 4 weeks post-intervention
|
Patient-Reported Outcomes Measurement Information System Sleep 8b (PROMIS Sleep 8b) is an 8-item self-report measure of sleep quality over the past 7 days with raw scores ranging from 8 to 40 and standardized T scores ranging from 28.9 to 76.5. |
From enrollment to 4 weeks post-intervention
|
|
Change in loneliness from baseline to 4 weeks post-intervention
Délai: From enrollment to 4 weeks post-intervention
|
Revised UCLA Loneliness Scale is a 20-item self-report measure of loneliness with scores ranging from 20 to 80. |
From enrollment to 4 weeks post-intervention
|
|
Change in alcohol use from baseline to 4 weeks post-intervention
Délai: From enrollment to 4 weeks post-intervention
|
Alcohol Use Disorder Identification Test (AUDIT) is a 10-item self-report measure of alcohol use with scores ranging from 0 to 40. |
From enrollment to 4 weeks post-intervention
|
|
Change in cannabis use from baseline to 4 weeks post-intervention
Délai: From enrollment to 4 weeks post-intervention
|
Cannabis Use Disorder Identification Test (CUDIT) is an 8-item self-report measure of cannabis use with scores ranging from 0 to 32. |
From enrollment to 4 weeks post-intervention
|
|
Change in salivary oxytocin levels from baseline to 4 weeks post-intervention
Délai: From enrollment to 4 weeks post-intervention
|
Oxytocin is a neurotransmitter that plays a role in determining social behavior. Salivary oxytocin levels range from 6.4-1000 pg/mL. |
From enrollment to 4 weeks post-intervention
|
|
Change in Interleukin-1 beta (IL-1β) from baseline to 4 weeks post-intervention
Délai: From enrollment to 4 weeks post-intervention
|
IL-1β is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. IL-1β is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
|
Change in Interleukin-6 (IL-6) from baseline to 4 weeks post-intervention
Délai: From enrollment to 4 weeks post-intervention
|
IL-6 is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. IL-6 is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
|
Change in tumor necrosis factor-alpha (TNF-alpha) from baseline to 4 weeks post-intervention
Délai: From enrollment to 4 weeks post-intervention
|
TNF-alpha is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. TNF-alpha is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in alcohol demand for participants who answer "yes" to alcohol consumption in the AUDIT measure from baseline to 4 weeks post-intervention
Délai: From enrollment to 4 weeks post-intervention
|
Alcohol Purchase Task is a tool to measure alcohol demand by asking individuals how many drinks they would consume at prices ranging from free to high, using behavioral economic indices for scoring. |
From enrollment to 4 weeks post-intervention
|
|
Change in cannabis demand for participants who answer "yes" to cannabis use from baseline to 4 weeks post-intervention
Délai: From enrollment to 4 weeks post-intervention
|
Cannabis Purchase Task is a tool to measure cannabis demand by assessing how much an individual purchases at increasing prices. |
From enrollment to 4 weeks post-intervention
|
|
Change in Magnetic Resonance Imaging (MRI) biomarkers from baseline to 4 weeks post-intervention
Délai: Pre-intervention and 4 weeks post-intervention
|
Optional participation in an MRI to detect changes in the structure and resting-state function of specific brain regions (anterior cingulate, amygdala, hippocampus, and insula) |
Pre-intervention and 4 weeks post-intervention
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Beth A Pratt, PhD, Florida Atlantic University
- Chercheur principal: Cheryl A Krause-Parello, PhD, Florida Atlantic University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- IRB2310227
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .